Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cellular Biomedicine (CBMG)

Cellular Biomedicine (CBMG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 358,824
  • Shares Outstanding, K 19,459
  • Annual Sales, $ 340 K
  • Annual Income, $ -49,980 K
  • 60-Month Beta 1.49
  • Price/Sales 1,043.35
  • Price/Cash Flow N/A
  • Price/Book 20.53
Trade CBMG with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.98 +9.40%
on 11/06/20
18.72 -0.80%
on 11/25/20
+0.16 (+0.87%)
since 10/23/20
3-Month
16.98 +9.40%
on 11/06/20
18.96 -2.06%
on 08/26/20
-0.03 (-0.16%)
since 08/25/20
52-Week
11.48 +61.76%
on 03/16/20
19.50 -4.77%
on 08/12/20
+0.68 (+3.80%)
since 11/25/19

Most Recent Stories

More News
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, CXO, and EIGI

NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Lifshitz Law Firm, P.C.:

CBMG : 18.57 (+0.70%)
CBLI : 3.07 (+1.99%)
CXO : 63.94 (-0.91%)
EIGI : 9.44 (unch)
WeissLaw LLP Reminds HDS, TCO, CBMG, and CCR Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

HDS : 55.80 (+0.09%)
TCO : 42.77 (+0.02%)
CBMG : 18.57 (+0.70%)
CCR : 4.37 (+3.55%)
Cellular Biomedi Shares Up 21.4% Since SmarTrend's Buy Recommendation (CBMG)

SmarTrend identified an Uptrend for Cellular Biomedi (NASDAQ:CBMG) on August 10th, 2020 at $14.82. In approximately 3 months, Cellular Biomedi has returned 21.43% as of today's recent price of $17.99....

CBMG : 18.57 (+0.70%)
Halper Sadeh LLP Announces it is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - PNM, STND, CBMG, CGIX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

PNM : 49.08 (-0.04%)
STND : 32.95 (+0.24%)
CBMG : 18.57 (+0.70%)
CGIX : 2.33 (+4.02%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds LOAC, SMMCU, CCR, and CBMG Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

LOAC : 11.08 (+0.82%)
SMMCU : 13.50 (+3.93%)
CCR : 4.37 (+3.55%)
CBMG : 18.57 (+0.70%)
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm - CBMG, MVC, PTI, CGIX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

CBMG : 18.57 (+0.70%)
MVC : 8.54 (+1.07%)
PTI : 1.0500 (+3.96%)
CGIX : 2.33 (+4.02%)
Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE:ARA), BMC Stock Holdings, Inc. (NASDAQ:BMCH), Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) and Inphi Corporation (NASDAQ:IPHI)

NEW YORK, NY / ACCESSWIRE / November 13, 2020 /

ARA : 11.44 (-0.09%)
BMCH : 48.50 (+0.06%)
CBMG : 18.57 (+0.70%)
IPHI : 149.99 (-0.46%)
Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders....

RESI : 16.44 (-0.18%)
CGIX : 2.33 (+4.02%)
CBMG : 18.57 (+0.70%)
CXO : 63.94 (-0.91%)
Cellular Biomedicine: 3Q Earnings Snapshot

NEW YORK (AP) _ Cellular Biomedicine Group Inc. (CBMG) on Monday reported a loss of $17 million in its third quarter.

CBMG : 18.57 (+0.70%)
Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights

and , /PRNewswire/ --  (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases,...

CBMG : 18.57 (+0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments...

See More

Key Turning Points

2nd Resistance Point 18.66
1st Resistance Point 18.55
Last Price 18.57
1st Support Level 18.22
2nd Support Level 18.00

See More

52-Week High 19.50
Last Price 18.57
Fibonacci 61.8% 16.44
Fibonacci 50% 15.49
Fibonacci 38.2% 14.54
52-Week Low 11.48

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar